US3897337A - Plasma separator assembly having interface-seeking piston with centrifugal valve - Google Patents

Plasma separator assembly having interface-seeking piston with centrifugal valve Download PDF

Info

Publication number
US3897337A
US3897337A US446370A US44637074A US3897337A US 3897337 A US3897337 A US 3897337A US 446370 A US446370 A US 446370A US 44637074 A US44637074 A US 44637074A US 3897337 A US3897337 A US 3897337A
Authority
US
United States
Prior art keywords
piston
assembly
phase
filter
diaphragm
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US446370A
Inventor
Waldemar A Ayres
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Becton Dickinson and Co
Original Assignee
Becton Dickinson and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Becton Dickinson and Co filed Critical Becton Dickinson and Co
Priority to US446370A priority Critical patent/US3897337A/en
Application granted granted Critical
Publication of US3897337A publication Critical patent/US3897337A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/502Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
    • B01L3/5021Test tubes specially adapted for centrifugation purposes
    • B01L3/50215Test tubes specially adapted for centrifugation purposes using a float to separate phases

Definitions

  • ABSTRACT A blood collection and separator assembly of the type suitable for centrifuging to separate the plasma or serum from the cellular phase of blood is disclosed.
  • the assembly includes a collection container and an interface-seeking piston having a centrifugal valve associated therewith being slidably disposed therein for opening the valve during centrifugation and for sealing off the plasma or serum phase from the cellular or heavy phase of blood after centrifuging is terminated.
  • the piston is formed having a specific gravity greater than the specific gravity of blood.
  • the piston is provided with a valve assembly which automatically opens the valve when the assembly is subjected to centrifugal force.
  • a filter assembly Disposed in tandem relationship with the valve means is a filter assembly to filter the plasma 136, 314, 316', 233/1 A, l R, 26 or serum as it passes through the valve means when the assembly is being centrifuged and the piston is [56] References Cited moving downwardly into the container.
  • the piston au- UNITED STATES PATENTS tomatically stops at the plasma/serum-cellular inter- 2,577,7s0 12/1951 Lockhart 128/272 X face by cloggmg the filter assembly.wlth T cellular 3 539 300 11/1970 Stone n ZIO/DIG. 24 phase.
  • valve means When the centrifugal force 18 terminated the 3:647:07) 3/1972 Adler I l 210/83 valve means is closed and the piston forms a barrier 3,661,265 5/1972 Greenspan 210/359 between the plasma or Serum Phase and the cellular 3,741,400 6/1973 Dick 2lO/DIG. 23 phase. 3,782,548 1/1974 Bowen 2l0/D1G. 23
  • This invention plasma/serum generally to plasma/- serum separator assemblies and particularly to a plasma/serving separator having an interface-seeking piston with a centrifugal valve assembly.
  • the piston is slidably disposed in a collection container for receiving blood.
  • the piston includes valve means which is normally closed but which will automatically open when the assembly is subjected to centrifugal force.
  • the piston also includes a filter means disposed in fluid communication with the valve means so that as the plasma or serum passes through the valve means it is filtered to remove any solid materials that may be present in the plasma or serum phase and which provides means for stopping the piston at the interface between the serum/plasma and cellular phase.
  • My invention generally contemplates the provision of a separator assembly which includes a blood collection container for receiving blood, the container having at least one open end which is adapted to receive a closure for sealing the end of the container.
  • An interfaceseeking piston is formed having a specific gravity greater than the specific gravity of blood and having a centrifugal valve means which automatically opens when the assembly is subjected to centrifugal force.
  • a filter assembly is disposed in the piston in fluid communication with the valve means so that the plasma and/or serum after passing through the valve means is filtered to remove any solid materials contained therein. The piston automatically stops when the filter assembly becomes clogged with the heavy phase at the plasma/- serum-cellular interface.
  • FIG. 1 is a sectional, elevational view of the plasma/- serum separator assembly illustrating a pointed cannula penetrating one of the stoppered ends of the container through which blood is introduced into the container prior to its separation.
  • FIG. 2 is an enlarged sectional, elevational view partly broken away illustrating the position of the piston approaching the plasma/serum-cellular interface while the assembly is being centrifuged.
  • separator assembly 10 comprises a tubular member or container 12 which is sealed at its open ends by closure members 14 and 15.
  • Closure members 14 and 15 are preferably made of elastomeric material, for example, rubber, and are capable of being penetrated by a cannula 16 so that blood can be transferred from a blood source into the container under aseptic conditions.
  • Closures 14 and 15 should be self-sealing so that when the cannula is removed from closure 14 there will be no loss of blood passing through the penetration portion of closure 14.
  • blood is being conducted through cannula l6 and is shown filling container 12 to about the point where piston 18 is positioned adjacent closure member 15.
  • cannula 16 is removed and assembly 10 is ready for centrifuging for subsequent separation of the collected blood into the plasma or serum phase and the cellular phase.
  • apertures 37 of diaphragm 36 remain closed while blood is filling container 12 and will not accidentally open by the pressure differential between blood at atmospheric pressure and the vacuum that is present in the filter 40 and at the top surface of diaphragm 36.
  • piston 18 Disposed in container 12 is piston 18 which includes a tubular metal insert 22 which is mounted in the annular recess 23 of piston 18.
  • Metal insert 22 is preferably made of stainless steel or other rigid chemically inert material having a specific gravity substantially greater than blood.
  • the body of piston 18 is preferably formed of elastomeric material and is provided with annular recess 23 which is dimensioned to receive tubular member 22 in an interference fit so that no air space remains in annular recess 23.
  • the elastomeric portion of piston 18 comprises an outer wall 26 and spaced therefrom is inner wall 28 in which their respective wall surfaces define annular recess 23.
  • inner wall 28 Formed integrally with wall 26 is a plurality of radially spaced resilient sealing rings 30 which contact the inner wall surface of container 12 in sealing liquidtight engagement.
  • Piston 18 when mounted in the container will maintain a liquidtight sealing contact with the inner wall of container 12 throughout the pistons path of travel within the container during centrifuging.
  • a longitudinally extending bore 32 provides a chamber for housing filter assembly 40.
  • Valve means 34 includes a resilient diaphragm 36 and weighted mass 39.
  • Diaphragm 36 is formed across the lower end of piston 18 to provide a barrier or closure for bore 32 and is made of a suitable elastomer, for example rubber. Also, positioned adjacent valve means 34, in bore 32, is filter assembly 40. Positioned within bore 32 and contacting the inner face of diaphragm 36 is a weighted mass or tubular insert 39 preferably cylindrical and having a diameter substantially less than the diameter of bore 32 which provides centrifugal valve opening means for diaphragm 36. Mass 39 has a loose fit relative to filter assembly 40. When the blood separator assembly is centrifuged to effect separation of the cellular phase from the plasma or serum phase, mass 39 presses against diaphragm 36 with sufficient force to stretch diaphragm 36 downwardly to thereby open apertures 37.
  • filter assembly 40 includes coarse filter 42 which is mounted in bore 32 of piston 18 and fine filter 44 which is secured with a suitable adhesive on to piston 18 so that it covers the upper opening of bore 32.
  • Filter 42 has an interference fit relative to bore 32 so that filter 42 remains in fixed position.
  • Diaphragm 38 is also made of a suitable elastomer, for example rubber, and is cemented or otherwise secured to the top of wall 26 of piston 18.
  • Diaphragm 38 is formed having one or more apertures or slits which are normally closed but which are opened when plasma/serum is passing through piston 18 as illustrated by the direction of the arrows in FIG. 2.
  • Fine filter 44 has average pore openings less than the average diameter of the red blood cells so that any plasma or serum containing solid materials of the diameter of a red blood cell or larger will be removed by filter 44 before passing through apertures 39 of diaphragm 38.
  • Coarse filter 42 has an average pore size greater than the cellular phase of blood and serves as a prefilter to take out larger particles such as fibrin strands or clots from the plasma or serum before it reaches fine filter 44.
  • FIG. 2 which is an enlarged sectional view partly broken away, illustrates the position of piston 18 approaching the plasma/serum-cellular interface 50 during centrifugation and before the cells pass through coarse filter 42 and clog fine filter 44 thereby stopping the descent of piston 18 at the interface.
  • apertures 37 and 41 of diaphragms 36 and 38 are open during the descent of piston 18 in container 12 but apertures 41 will automatically close when fine filter 44 clogs with red cells while apertures 37 of diaphragm 36 remain open even though centrifuging continues. When centrifuging ceases apertures 37 of diaphragm 36 will automatically close.
  • piston 18 has a specific gravity substantially greater than the specific gravity of blood.
  • piston 18 will automatically stop at the plasma/- serum-cellular interface 50 when filter 44 of piston 18 becomes clogged with the heavy cellular phase, such as the red blood cells, thereby separating the light phase plasma or serum from the heavy phase cellular material of blood and will form a barrier between the two phases when centrifuging is completed.
  • the heavy cellular phase such as the red blood cells
  • assembly 10 When using the assembly illustrated in FIGS. 1 and 2 after the blood has been collected, assembly 10 is placed in a centrifuge and, at first, is subjected to a spin speed which is suitable to cause the heavy or cellular phase material to pass downwardly in the container toward stopper 14 but the spin speed is insufficient to cause the piston 18 to slide downwardly through the plasma/serum phase. Then, the assembly is subjected to a higher spin speed which causes mass 39 to press downwardly on diaphragm 36 additionally to open apertures 37 in piston 18. Piston 18 then starts its movement downwardly in the container and separated plasma or serum pass through apertures 37 and through coarse filter 42 and fine filter 44.
  • a spin speed which is suitable to cause the heavy or cellular phase material to pass downwardly in the container toward stopper 14 but the spin speed is insufficient to cause the piston 18 to slide downwardly through the plasma/serum phase. Then, the assembly is subjected to a higher spin speed which causes mass 39 to press downwardly on diaphragm 36 additionally to open apertures 37
  • a plasma/serum separator assembly in which an interfaceseeking piston with a centrifugal valve is disclosed the assembly is described in which blood can be collected, centrifuged, separated into its component phases and is capable of being shipped through the mail for further analytical determinations without the plasma or serum mixing with the cellular phase even though the assembly is inverted and handled roughly.
  • a separator assembly capable of separating blood into a plasma/serum or light phase and a cellular or heavy phase comprising:
  • a container having at least one open end which is adapted to receive blood for subsequent separation into a light phase and a heavy phase;
  • closure sealing the open end of the container, the closure being formed of a self-sealing, elastomeric material which is penetrable by a cannula through which blood to be separated is conducted into the container;
  • an interface-seeking piston having a specific gravity relatively greater than blood and slidably mounted in the container adjacent one end thereof and being movable downwardly in said container due to the influence of centrifugal force and having means on an outer surface for providing sealing engagement with an inner surface of the container;
  • valve assembly mounted on the piston and disposed at the lower end thereof, said assembly comprises a lower resilient diaphragm mounted on the lower end of said piston and having apertures formed therein, said apertures being normally closed and adapted to open during the downward movement of the piston; an upper resilient diaphragm mounted on the upper end of said piston, having apertures formed therein, said apertures being normally closed and adapted to open during the downward movement of the piston;
  • a filter assembly mounted between said valve assembly and said upper diaphragm and being in fluid communication with the valve assembly, said filter assembly including a lower coarse filter having an average pore opening larger than the diameter of blood cells, disposed adjacent said valve assembly and an upper fine filter having an average pore opening smaller than the diameter of blood cells, said fine filter disposed between the upper diaphragm and said coarse filter, said filter assembly being capable of removing substantially all solid material from the separated plasma/serum phase;
  • said fine filter providing piston stop means when said piston is at the plasma/serum-cellular interface whereby the cellular phase clogs the fine filter to prevent further upward flow of fluid through the fine filter so that the piston automatically stops at said interface and the upper diaphragm apertures close.
  • valve assembly includes a weight mass disposed on the upper surface of said lower diaphragm, said mass being forced downward against the lower resilient diaphragm when the assembly is subjected to centrifugal force whereby said lower diaphragm is stretched and the apertures therein are opened.
  • An interface-seeking piston adapted for use for separating the serum or plasma phase from the cellular phase of blood in a separator assembly including a container, said piston having a specific gravity relatively greater than blood and adapted to be slidably mounted adjacent one end of the container and movable downwardly in said container due to the influence of centrifugal force and having means on an outer surface thereof for providing sealing engagement with an inner surface of the container;
  • valve assembly mounted on the piston and disposed at the lower end thereof, said assembly comprises a lower resilient diaphragm mounted on the lower end of said piston and having apertures therein, said apertures being normally closed and adapted to open during the downward movement of the piston;
  • a resilient upper diaphragm having apertures formed therein and mounted at the upper end of said piston with said apertures being normally closed and adapted to open during the downward movement of the piston;
  • a filter assembly mounted between said valve assembly and said upper diaphragm and being in fluid communication with the valve assembly, said filter assembly including a lower coarse filter having an average pore opening larger than the cellular phase, disposed adjacent said valve assembly and an upper fine filter having an average pore opening smaller than cellular phase; said fine filter disposed between said upper diaphragm and said coarse filter, said filter assembly being capable of removing substantially all solid material from the separated plasma/serum phase and said fine filter being adapted to provide piston stop means when said piston is at the plasma/serum-cellular interface.
  • valve assembly includes a weight-mass disposed on the upper surface of said lower diaphragm, said mass being forced downward against the resilient lower diaphragm when the piston is subjected to centrifugal force whereby said lower diaphragm is stretched and the apertures therein are opened.

Abstract

A blood collection and separator assembly of the type suitable for centrifuging to separate the plasma or serum from the cellular phase of blood is disclosed. The assembly includes a collection container and an interface-seeking piston having a centrifugal valve associated therewith being slidably disposed therein for opening the valve during centrifugation and for sealing off the plasma or serum phase from the cellular or heavy phase of blood after centrifuging is terminated. The piston is formed having a specific gravity greater than the specific gravity of blood. The piston is provided with a valve assembly which automatically opens the valve when the assembly is subjected to centrifugal force. Disposed in tandem relationship with the valve means is a filter assembly to filter the plasma or serum as it passes through the valve means when the assembly is being centrifuged and the piston is moving downwardly into the container. The piston automatically stops at the plasma/serumcellular interface by clogging the filter assembly with the cellular phase. When the centrifugal force is terminated the valve means is closed and the piston forms a barrier between the plasma or serum phase and the cellular phase.

Description

United States Patent Ayres INTERFACE-SEEKING PISTON WITH CENTRIFUGAL VALVE PLASMA SEPARATOR ASSEMBLY HAVING [75] Inventor: Waldemar A. Ayres, Rutherford,
[73] Assignee: Becton, Dickinson and Company,
East Rutherford, NJ.
[ Notice: The portion of the term of this patent subsequent to July 15, 1992, has been disclaimed.
[22] Filed: Feb. 27, 1974 [21] Appl. No.: 446,370
[52] US. Cl. 210/136; 210/314; 210/359;
210/516; 210/DIG. 23
[51] Int. Cl B01d 21/26 [58] Field of Search 23/230 B, 258.5, 259, 292;
128/2 F, 214 R, 218 M, 272; 210/83, 84, 109,131, 359, 514-518, DIG. 23, DIG. 24,
Primary Examiner-John Adee Assistant EraminerRobert H. Spitzer Attorney, Agent, or Firm-Kane, Dalsimer, Kane, Sullivan and Kurucz [57] ABSTRACT A blood collection and separator assembly of the type suitable for centrifuging to separate the plasma or serum from the cellular phase of blood is disclosed. The assembly includes a collection container and an interface-seeking piston having a centrifugal valve associated therewith being slidably disposed therein for opening the valve during centrifugation and for sealing off the plasma or serum phase from the cellular or heavy phase of blood after centrifuging is terminated. The piston is formed having a specific gravity greater than the specific gravity of blood. The piston is provided with a valve assembly which automatically opens the valve when the assembly is subjected to centrifugal force. Disposed in tandem relationship with the valve means is a filter assembly to filter the plasma 136, 314, 316', 233/1 A, l R, 26 or serum as it passes through the valve means when the assembly is being centrifuged and the piston is [56] References Cited moving downwardly into the container. The piston au- UNITED STATES PATENTS tomatically stops at the plasma/serum-cellular inter- 2,577,7s0 12/1951 Lockhart 128/272 X face by cloggmg the filter assembly.wlth T cellular 3 539 300 11/1970 Stone n ZIO/DIG. 24 phase. When the centrifugal force 18 terminated the 3:647:07) 3/1972 Adler I l 210/83 valve means is closed and the piston forms a barrier 3,661,265 5/1972 Greenspan 210/359 between the plasma or Serum Phase and the cellular 3,741,400 6/1973 Dick 2lO/DIG. 23 phase. 3,782,548 1/1974 Bowen 2l0/D1G. 23
6 Claims, 2 Drawing Figures IO "T= 1::
1 PLASMA SEPARATOR ASSEMBLY HAVING INTERFACE-SEEKING PISTON WITH CENTRIFUGAL VALVE BACKGROUND OF THE INVENTION This invention plasma/serum generally to plasma/- serum separator assemblies and particularly to a plasma/serving separator having an interface-seeking piston with a centrifugal valve assembly. The piston is slidably disposed in a collection container for receiving blood. The piston includes valve means which is normally closed but which will automatically open when the assembly is subjected to centrifugal force. The piston also includes a filter means disposed in fluid communication with the valve means so that as the plasma or serum passes through the valve means it is filtered to remove any solid materials that may be present in the plasma or serum phase and which provides means for stopping the piston at the interface between the serum/plasma and cellular phase.
DESCRIPTION OF THE PRIOR ART It is known to separate blood into its component parts by centrifugation, for example, the assembly disclosed in U.S. Pat. No. 2,460,641. However, this particular assembly does not employ a means for sealing the separated plasma or serum phase from the cellular phase.
It is also known to provide assemblies for manually separating the plasma or serum phase from the cellular phase, for example, as disclosed in U.S. Pat. Nos. 3,586,064; 3,661,265; 3,355,098; 3,481,477; 3,512,940 and 3,693,804. In all of these devices the serum is collected in a blood collection container and means are provided for separating the plasma or serum phase from the cellular phase employing filters, valves, transfer tubes or the like.
It is also known to provide assemblies for the sealed separation of blood in which a piston is actuated by centrifugal force such as is disclosed in US. Pat. Nos. 3,508,653 and 3,779,383. These devices use either a deformable piston made of a resilient material or valve means associated with the piston to effect a sealed separation after centrifugation.
SUMMARY OF THE INVENTION It is an object of the present invention to provide a plasma/serum separator assembly in which an interface-seeking piston automatically stops when centrifuged at the plasma/serum-cellular interface.
It is another object of the invention to provide a piston having a centrifugal valve means that will not be accidentally opened when the container is being filled with blood by the pressure difference of blood at atmospheric pressure and the vacuum on the other side of the valve. It is also an object of the invention to provide a piston having a filter assembly which will prevent cellular materials contained in the blood from passing into the separated plasma or serum phase.
It is another object of the invention to provide a plas ma/serum separator assembly which is economical to manufacture and can be used in conjunction with standard blood collecting equipment.
My invention generally contemplates the provision of a separator assembly which includes a blood collection container for receiving blood, the container having at least one open end which is adapted to receive a closure for sealing the end of the container. An interfaceseeking piston is formed having a specific gravity greater than the specific gravity of blood and having a centrifugal valve means which automatically opens when the assembly is subjected to centrifugal force. A filter assembly is disposed in the piston in fluid communication with the valve means so that the plasma and/or serum after passing through the valve means is filtered to remove any solid materials contained therein. The piston automatically stops when the filter assembly becomes clogged with the heavy phase at the plasma/- serum-cellular interface.
DESCRIPTION OF THE DRAWINGS For a better understanding of the invention reference is had to the drawings which illustrate a preferred embodiment of the invention herein.
FIG. 1 is a sectional, elevational view of the plasma/- serum separator assembly illustrating a pointed cannula penetrating one of the stoppered ends of the container through which blood is introduced into the container prior to its separation.
FIG. 2 is an enlarged sectional, elevational view partly broken away illustrating the position of the piston approaching the plasma/serum-cellular interface while the assembly is being centrifuged.
DESCRIPTION OF THE PREFERRED EMBODIMENTS For a better understanding of the invention herein a description of the preferred embodiment is had which is illustrated in FIGS. 1 and 2.
In FIG. 1 separator assembly 10 comprises a tubular member or container 12 which is sealed at its open ends by closure members 14 and 15. Closure members 14 and 15 are preferably made of elastomeric material, for example, rubber, and are capable of being penetrated by a cannula 16 so that blood can be transferred from a blood source into the container under aseptic conditions. Closures 14 and 15 should be self-sealing so that when the cannula is removed from closure 14 there will be no loss of blood passing through the penetration portion of closure 14. As depicted in FIG. 1, blood is being conducted through cannula l6 and is shown filling container 12 to about the point where piston 18 is positioned adjacent closure member 15. Thereafter, cannula 16 is removed and assembly 10 is ready for centrifuging for subsequent separation of the collected blood into the plasma or serum phase and the cellular phase. In this connection, apertures 37 of diaphragm 36 remain closed while blood is filling container 12 and will not accidentally open by the pressure differential between blood at atmospheric pressure and the vacuum that is present in the filter 40 and at the top surface of diaphragm 36.
Disposed in container 12 is piston 18 which includes a tubular metal insert 22 which is mounted in the annular recess 23 of piston 18. Metal insert 22 is preferably made of stainless steel or other rigid chemically inert material having a specific gravity substantially greater than blood. The body of piston 18 is preferably formed of elastomeric material and is provided with annular recess 23 which is dimensioned to receive tubular member 22 in an interference fit so that no air space remains in annular recess 23.
The elastomeric portion of piston 18 comprises an outer wall 26 and spaced therefrom is inner wall 28 in which their respective wall surfaces define annular recess 23. Formed integrally with wall 26 is a plurality of radially spaced resilient sealing rings 30 which contact the inner wall surface of container 12 in sealing liquidtight engagement. Piston 18 when mounted in the container will maintain a liquidtight sealing contact with the inner wall of container 12 throughout the pistons path of travel within the container during centrifuging. A longitudinally extending bore 32 provides a chamber for housing filter assembly 40. Valve means 34 includes a resilient diaphragm 36 and weighted mass 39. Diaphragm 36 is formed across the lower end of piston 18 to provide a barrier or closure for bore 32 and is made of a suitable elastomer, for example rubber. Also, positioned adjacent valve means 34, in bore 32, is filter assembly 40. Positioned within bore 32 and contacting the inner face of diaphragm 36 is a weighted mass or tubular insert 39 preferably cylindrical and having a diameter substantially less than the diameter of bore 32 which provides centrifugal valve opening means for diaphragm 36. Mass 39 has a loose fit relative to filter assembly 40. When the blood separator assembly is centrifuged to effect separation of the cellular phase from the plasma or serum phase, mass 39 presses against diaphragm 36 with sufficient force to stretch diaphragm 36 downwardly to thereby open apertures 37.
As shown in FIG. 2, filter assembly 40 includes coarse filter 42 which is mounted in bore 32 of piston 18 and fine filter 44 which is secured with a suitable adhesive on to piston 18 so that it covers the upper opening of bore 32. Filter 42 has an interference fit relative to bore 32 so that filter 42 remains in fixed position. Diaphragm 38 is also made of a suitable elastomer, for example rubber, and is cemented or otherwise secured to the top of wall 26 of piston 18. Diaphragm 38 is formed having one or more apertures or slits which are normally closed but which are opened when plasma/serum is passing through piston 18 as illustrated by the direction of the arrows in FIG. 2.
Fine filter 44 has average pore openings less than the average diameter of the red blood cells so that any plasma or serum containing solid materials of the diameter of a red blood cell or larger will be removed by filter 44 before passing through apertures 39 of diaphragm 38. Coarse filter 42 has an average pore size greater than the cellular phase of blood and serves as a prefilter to take out larger particles such as fibrin strands or clots from the plasma or serum before it reaches fine filter 44.
FIG. 2, which is an enlarged sectional view partly broken away, illustrates the position of piston 18 approaching the plasma/serum-cellular interface 50 during centrifugation and before the cells pass through coarse filter 42 and clog fine filter 44 thereby stopping the descent of piston 18 at the interface. It should be noted that apertures 37 and 41 of diaphragms 36 and 38 are open during the descent of piston 18 in container 12 but apertures 41 will automatically close when fine filter 44 clogs with red cells while apertures 37 of diaphragm 36 remain open even though centrifuging continues. When centrifuging ceases apertures 37 of diaphragm 36 will automatically close. It should be noted that piston 18 has a specific gravity substantially greater than the specific gravity of blood. However, piston 18 will automatically stop at the plasma/- serum-cellular interface 50 when filter 44 of piston 18 becomes clogged with the heavy cellular phase, such as the red blood cells, thereby separating the light phase plasma or serum from the heavy phase cellular material of blood and will form a barrier between the two phases when centrifuging is completed.
When using the assembly illustrated in FIGS. 1 and 2 after the blood has been collected, assembly 10 is placed in a centrifuge and, at first, is subjected to a spin speed which is suitable to cause the heavy or cellular phase material to pass downwardly in the container toward stopper 14 but the spin speed is insufficient to cause the piston 18 to slide downwardly through the plasma/serum phase. Then, the assembly is subjected to a higher spin speed which causes mass 39 to press downwardly on diaphragm 36 additionally to open apertures 37 in piston 18. Piston 18 then starts its movement downwardly in the container and separated plasma or serum pass through apertures 37 and through coarse filter 42 and fine filter 44. The hydrostatic pressure of the plasma/serum exerted against diaphragm 38 causes it to stretch upwardly thereby opening valve apertures 41 to permit the passage of separated plasma or serum to the top side of piston 18. When piston 18 reaches the plasma/serum-cellular interface, red cells and other portions of the cellular phase pass through coarse filter 42 and are stopped by fine filter 44 thereby causing filter 44 to become clogged and effectively stop piston 18 at the plasma/serum-cellular interface 50. Thereafter, even though centrifuging continues diaphragm 38 returns to its normal relaxed position as in FIG. 1 with apertures 41 closed. However, until centrifuging ceases apertures 37 of diaphragm 36 remain open due to mass 39 exerting a force against diaphragm 36. When centrifuging ceases, resilient diaphragm 36 moves mass 39 to its normal position thereby automatically closing apertures 37. When centrifuging is completed the piston is established as a sealed barrier at the interface between the serum/plasma phase and the cellular phase.
From the foregoing, it is readily observed that a plasma/serum separator assembly in which an interfaceseeking piston with a centrifugal valve is disclosed the assembly is described in which blood can be collected, centrifuged, separated into its component phases and is capable of being shipped through the mail for further analytical determinations without the plasma or serum mixing with the cellular phase even though the assembly is inverted and handled roughly.
While variations of the invention herein may be had the objectives of the invention have been illustrated and described and it is contemplated that changes in design can be made without departing from the spirit of the invention described herein.
What is claimed is:
1. A separator assembly capable of separating blood into a plasma/serum or light phase and a cellular or heavy phase comprising:
a container having at least one open end which is adapted to receive blood for subsequent separation into a light phase and a heavy phase;
a closure sealing the open end of the container, the closure being formed of a self-sealing, elastomeric material which is penetrable by a cannula through which blood to be separated is conducted into the container;
an interface-seeking piston having a specific gravity relatively greater than blood and slidably mounted in the container adjacent one end thereof and being movable downwardly in said container due to the influence of centrifugal force and having means on an outer surface for providing sealing engagement with an inner surface of the container;
a valve assembly mounted on the piston and disposed at the lower end thereof, said assembly comprises a lower resilient diaphragm mounted on the lower end of said piston and having apertures formed therein, said apertures being normally closed and adapted to open during the downward movement of the piston; an upper resilient diaphragm mounted on the upper end of said piston, having apertures formed therein, said apertures being normally closed and adapted to open during the downward movement of the piston;
a filter assembly mounted between said valve assembly and said upper diaphragm and being in fluid communication with the valve assembly, said filter assembly including a lower coarse filter having an average pore opening larger than the diameter of blood cells, disposed adjacent said valve assembly and an upper fine filter having an average pore opening smaller than the diameter of blood cells, said fine filter disposed between the upper diaphragm and said coarse filter, said filter assembly being capable of removing substantially all solid material from the separated plasma/serum phase; and
said fine filter providing piston stop means when said piston is at the plasma/serum-cellular interface whereby the cellular phase clogs the fine filter to prevent further upward flow of fluid through the fine filter so that the piston automatically stops at said interface and the upper diaphragm apertures close.
2. The separator assembly of claim 1 wherein the valve assembly includes a weight mass disposed on the upper surface of said lower diaphragm, said mass being forced downward against the lower resilient diaphragm when the assembly is subjected to centrifugal force whereby said lower diaphragm is stretched and the apertures therein are opened.
3. The separator assembly of claim 1 wherein said filter assembly is disposed in a passage formed through said piston, the upper and lower ends of said passage being closed by said upper and lower resilient diaphragms respectively.
4. An interface-seeking piston adapted for use for separating the serum or plasma phase from the cellular phase of blood in a separator assembly including a container, said piston having a specific gravity relatively greater than blood and adapted to be slidably mounted adjacent one end of the container and movable downwardly in said container due to the influence of centrifugal force and having means on an outer surface thereof for providing sealing engagement with an inner surface of the container;
a valve assembly mounted on the piston and disposed at the lower end thereof, said assembly comprises a lower resilient diaphragm mounted on the lower end of said piston and having apertures therein, said apertures being normally closed and adapted to open during the downward movement of the piston;
a resilient upper diaphragm having apertures formed therein and mounted at the upper end of said piston with said apertures being normally closed and adapted to open during the downward movement of the piston;
a filter assembly mounted between said valve assembly and said upper diaphragm and being in fluid communication with the valve assembly, said filter assembly including a lower coarse filter having an average pore opening larger than the cellular phase, disposed adjacent said valve assembly and an upper fine filter having an average pore opening smaller than cellular phase; said fine filter disposed between said upper diaphragm and said coarse filter, said filter assembly being capable of removing substantially all solid material from the separated plasma/serum phase and said fine filter being adapted to provide piston stop means when said piston is at the plasma/serum-cellular interface.
5. The piston of claim 4 wherein the valve assembly includes a weight-mass disposed on the upper surface of said lower diaphragm, said mass being forced downward against the resilient lower diaphragm when the piston is subjected to centrifugal force whereby said lower diaphragm is stretched and the apertures therein are opened.
6. The piston of claim 4 wherein said filter assembly is disposed in a passage formed through said piston, the upper and lower ends of said passage being closed by said upper and lower resilient diaphragms respectively.

Claims (6)

1. A SEPARATOR ASSEMBLY CAPABLE OF SEPARATING BLOOD INTO A PLASMA/SERUM ORLIGHT PHASE AND A CELLULAR OR HEAVY PHASE COMPRISING: A CONTAINER HAVING AT LEAST ONE OPEN ND WHICH IS ADAPTED TO RECEIVE BLOOD FOR SUBSEQUENT SEPARATION INTO A LIGHT PHASE AND A HEAVY PHASE, A CLOSURE SEALING THE OPEN END OF THE CONTAINER, THE CLOSURE BEING FORMED OF A SELF-SEALING, ELASTOMERIC MATERIAL EHICH IS PENETRABLE BY A CANNULA THROUGH WHICH BLOOD TO BE SEPARATED IS CONDUCTED INTO THE CONTAINER, AN INTERFACE-SEEKING PISTON HAVING A SPECIFIC GRAVITY RELATIVELY GREATER THAN BLOOD AND SLIDABLY MOUNTED IN THE CONTAINER ADJACENT ONE END THEREOF AND BEING MOVABLE DOWNWARDLY IN SAID CONTAINER DUE TO HE REFLUENCE OF CENTRIFUGAL FORCE AND HAVING MEANS ON AN OUTER SURFACE FOR PROVIDING SEALING ENGAGEMENT WITH AN INNER SURFACE OF THE CONTAINER, A VALVE ASSEMBLY MOUNTED ON THE PISTON AND DISPOSED AT THE LOWER END THEREOF, SAID ASSEMBLY COMPRISES A LOWER RESILIENT DIAPHRAGM MOUNTED ON THE LOWER END OF SAID PISTON AND HAVING APERTURES FORMED THEREIN, SAID APERTURES BEING NORMALLY CLOSED AND ADAPTED TO OPEN DURING THE DOWNWARD MOVEMENT OF THE PISTON, AN UPPER RESILIENT DIAPHRAGM MOUNTED ON THE UPPER END OF SAID PISTON, HAVING APERTURES FORMED THEREIN, SAID APERTURES BEING NORMALLY CLOSED AND ADAPTED TO OPEN DURING THE DOWNWARD MOVEMENT OF THE PISTON, A FILTER ASSEMBLY MOUNTED BETWEEN SAID VALVE ASSEMBLY AND SAID UPPER DIAPHRAGM AND BEING IN FLUID COMMUNICATION WITH THE VALVE ASSEMBLY, SAID FILTER ASSEMBLY INCLUDING A LOWER COARSE FILTER HAVING AN AVERAGE PORE OPENING LARGER THAN THE DIAMETER OF BLOOD CELLS, DISPOSED ADJACENT SAID VALVE ASSEMBLY AND AN UPPER FINE FILTER HAVING AN AVERAGE PORE OPENING SMALLER THAN THE DIAMETER OF BLOOD CELLS, SAID FINE FILTER DISPOSED BETWEEN THE UPPER IAPHRAGM SAID SAID COARSE FILTER, SAID FILTER ASSEMBLY BEING CAPABLE OF REMOVING SUBSTANTIALLY ALL SOLID MATERIAL FROM THE SEPARATED PLASMA/SERUM PHASE, AND SAID FINE FILTER PROVIDING PISTON STOP MEANS WHEN SAID PISTON IS AT THE PLASMA/SERUM-CELLULAR INTERFACE WHEREBY THE CELLULAR PHASE CLOGS THE FINE FILTER TO PREVENT FURTHER UPWARD FLOW OF FLUID THROUGH THE FINE FILTER SO THAT THE PISTON AUTOMATICALLY STOPS AT SAID INTERFACE AND THE UPPER DIAPHRAGM APERTURES CLOSE.
2. The separator assembly of claim 1 wherein the valve assembly includes a weight mass disposed on the upper surface of said lower diaphragm, said mass being forced downward against the lower resilient diaphragm when the assembly is subjected to centrifugal force whereby said lower diaphragm is stretched and the apertures therein are opened.
3. The separator assembly of claim 1 wherein said filter assembly is disposed in a passage formed through said piston, the upper and lower ends of said passage being closed by said upper and lower resilient diaphragms respectively.
4. An interface-seeking piston adapted for use for separating the serum or plasma phase from the cellular phase of blood in a separator assembly including a container, said piston having a specific gravity relatively greater than blood and adapted to be slidably mounted adjacent one end of the container and movable downwardly in said container due to the influence of centrifugal force and having means on an outer surface thereof for providing sealing engagement with an inner surface of the container; a valve assembly mounted on the piston and disposed at the lower end thereof, said assembly comprises a lower resilient diaphragm mounted on the lower end of said piston and having apertures therein, said apertures being normally closed and adapted to open during the downward movement of the piston; a resilient upper diaphragm having apertures formed therein and mounted at the upper end of said piston with said apertures being normally closed and adapted to open during the downward movement of the piston; a filter assembly mounted between said valve assembly and said upper diaphragm and being in fluid communication with the valve assembly, said filter assembly including a lower coarse filter having an average pore opening larger than the cellular phase, disposed adjacent said valve assembly and an upper fine filter having an average pore opening smaller than cellular phase; said fine filter disposed between said upper diaphragm and said coarse filter, said filter assembly being capable of removing substantially all solid material from the separated plasma/serum phase and said fine filter being adapted to provide piston stop means when said piston is at the plasma/serum-cellular interface.
5. The piston of claim 4 wherein the valve assembly includes a weight-mass disposed on the upper surface of said lower diaphragm, said mass being forced downward against the resilient lower diaphragm when the piston is subjected to centrifugal force whereby said lower diaphragm is stretched and the apertures therein are opened.
6. The piston of claim 4 wherein said filter assembly is disposed in a passage formed through said piston, the upper and lower ends of said passage being closed by said upper and lower resilient diaphragms respectively.
US446370A 1974-02-27 1974-02-27 Plasma separator assembly having interface-seeking piston with centrifugal valve Expired - Lifetime US3897337A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US446370A US3897337A (en) 1974-02-27 1974-02-27 Plasma separator assembly having interface-seeking piston with centrifugal valve

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US446370A US3897337A (en) 1974-02-27 1974-02-27 Plasma separator assembly having interface-seeking piston with centrifugal valve

Publications (1)

Publication Number Publication Date
US3897337A true US3897337A (en) 1975-07-29

Family

ID=23772336

Family Applications (1)

Application Number Title Priority Date Filing Date
US446370A Expired - Lifetime US3897337A (en) 1974-02-27 1974-02-27 Plasma separator assembly having interface-seeking piston with centrifugal valve

Country Status (1)

Country Link
US (1) US3897337A (en)

Cited By (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4152270A (en) * 1976-05-06 1979-05-01 Sherwood Medical Industries Inc. Phase separation device
US4490256A (en) * 1982-11-26 1984-12-25 Sartorius Gmbh Apparatus for static membrane filtration
US4492634A (en) * 1982-09-28 1985-01-08 Emde Medical Research Pre-evacuated blood collection tube with anti-hemolysis baffle system and centrifugation propelled filtration disc and efficient serum-from cells separator
US4811866A (en) * 1987-01-02 1989-03-14 Helena Laboratories Corporation Method and apparatus for dispensing liquids
US4818386A (en) * 1987-10-08 1989-04-04 Becton, Dickinson And Company Device for separating the components of a liquid sample having higher and lower specific gravities
US4957637A (en) * 1988-05-23 1990-09-18 Sherwood Medical Company Serum separator system for centrifuge with piercable membrane
US5393674A (en) * 1990-12-31 1995-02-28 Levine Robert A Constitutent layer harvesting from a centrifuged sample in a tube
US5860937A (en) * 1997-04-30 1999-01-19 Becton, Dickinson & Company Evacuated sample collection tube with aqueous additive
US20020094305A1 (en) * 1999-12-06 2002-07-18 Dicesare Paul C. Device and method for separating components of a fluid sample
AT409725B (en) * 1997-05-12 2002-10-25 Greiner & Soehne C A SEPARATOR
US20040217046A1 (en) * 2001-03-30 2004-11-04 Franz Konrad Holding device, particularly for body fluids, comprising a separating device, and a separating device therefor
US20070003449A1 (en) * 2005-06-10 2007-01-04 Mehdi Hatamian Valve for facilitating and maintaining fluid separation
EP1758628A1 (en) * 2004-06-23 2007-03-07 Medikan Co., Ltd. Syringe piston using in fat transplantation
US20070102344A1 (en) * 2005-10-04 2007-05-10 Franz Konrad Separating device, holding device and method for separation
WO2008013684A2 (en) * 2006-07-21 2008-01-31 Becton, Dickinson And Company Membrane-based double-layer tube for sample collections
US20080164223A1 (en) * 2007-01-05 2008-07-10 Wilson Kelce S Floating filter holder
US20080223815A1 (en) * 2004-01-23 2008-09-18 Franz Konrad Method for the Assembly of a Cap with a Receptacle
US20100160135A1 (en) * 2008-07-21 2010-06-24 Becton, Dickinson And Company Density Phase Separation Device
US20100288694A1 (en) * 2009-05-15 2010-11-18 Becton, Dickinson And Company Density Phase Separation Device
US8313954B2 (en) 2009-04-03 2012-11-20 Biomet Biologics, Llc All-in-one means of separating blood components
US8328024B2 (en) 2007-04-12 2012-12-11 Hanuman, Llc Buoy suspension fractionation system
US8337711B2 (en) 2008-02-29 2012-12-25 Biomet Biologics, Llc System and process for separating a material
US8394342B2 (en) 2008-07-21 2013-03-12 Becton, Dickinson And Company Density phase separation device
US8567609B2 (en) 2006-05-25 2013-10-29 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US8591391B2 (en) 2010-04-12 2013-11-26 Biomet Biologics, Llc Method and apparatus for separating a material
US8596470B2 (en) 2007-04-12 2013-12-03 Hanuman, Llc Buoy fractionation system
US8603346B2 (en) 2002-05-24 2013-12-10 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US20140112841A1 (en) * 2011-03-24 2014-04-24 Boehringer Ingelheim Microparts Gmbh Device and method for removing a supernatant of a liquid sample, and use of a valve device having a soluble membrane
US8783470B2 (en) 2009-03-06 2014-07-22 Biomet Biologics, Llc Method and apparatus for producing autologous thrombin
US8808551B2 (en) 2002-05-24 2014-08-19 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US8950586B2 (en) 2002-05-03 2015-02-10 Hanuman Llc Methods and apparatus for isolating platelets from blood
US9011800B2 (en) 2009-07-16 2015-04-21 Biomet Biologics, Llc Method and apparatus for separating biological materials
US9333445B2 (en) 2008-07-21 2016-05-10 Becton, Dickinson And Company Density phase separation device
US9393576B2 (en) 2000-04-28 2016-07-19 Harvest Technologies Corporation Blood components separator disk
US9556243B2 (en) 2013-03-15 2017-01-31 Biomet Biologies, LLC Methods for making cytokine compositions from tissues using non-centrifugal methods
US9642956B2 (en) 2012-08-27 2017-05-09 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US9682373B2 (en) 1999-12-03 2017-06-20 Becton, Dickinson And Company Device for separating components of a fluid sample
US9694359B2 (en) 2014-11-13 2017-07-04 Becton, Dickinson And Company Mechanical separator for a biological fluid
US9701728B2 (en) 2008-02-27 2017-07-11 Biomet Biologics, Llc Methods and compositions for delivering interleukin-1 receptor antagonist
US9895418B2 (en) 2013-03-15 2018-02-20 Biomet Biologics, Llc Treatment of peripheral vascular disease using protein solutions
US9897589B2 (en) 2002-05-24 2018-02-20 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US9950035B2 (en) 2013-03-15 2018-04-24 Biomet Biologics, Llc Methods and non-immunogenic compositions for treating inflammatory disorders
US10143725B2 (en) 2013-03-15 2018-12-04 Biomet Biologics, Llc Treatment of pain using protein solutions
US10576130B2 (en) 2013-03-15 2020-03-03 Biomet Manufacturing, Llc Treatment of collagen defects using protein solutions

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2577780A (en) * 1950-05-09 1951-12-11 Compule Corp Crowned cupped resilient plug for cylindrical passages
US3539300A (en) * 1967-10-23 1970-11-10 Schering Corp Body fluid collector and separator having improved flow rate
US3647070A (en) * 1970-06-11 1972-03-07 Technicon Corp Method and apparatus for the provision of fluid interface barriers
US3661265A (en) * 1970-07-27 1972-05-09 Contemporary Research And Dev Serum separator type container
US3741400A (en) * 1970-06-15 1973-06-26 J Dick Blood sample container
US3782548A (en) * 1972-12-07 1974-01-01 J Bowen Serum skimmer

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2577780A (en) * 1950-05-09 1951-12-11 Compule Corp Crowned cupped resilient plug for cylindrical passages
US3539300A (en) * 1967-10-23 1970-11-10 Schering Corp Body fluid collector and separator having improved flow rate
US3647070A (en) * 1970-06-11 1972-03-07 Technicon Corp Method and apparatus for the provision of fluid interface barriers
US3741400A (en) * 1970-06-15 1973-06-26 J Dick Blood sample container
US3661265A (en) * 1970-07-27 1972-05-09 Contemporary Research And Dev Serum separator type container
US3782548A (en) * 1972-12-07 1974-01-01 J Bowen Serum skimmer

Cited By (96)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4152270A (en) * 1976-05-06 1979-05-01 Sherwood Medical Industries Inc. Phase separation device
US4492634A (en) * 1982-09-28 1985-01-08 Emde Medical Research Pre-evacuated blood collection tube with anti-hemolysis baffle system and centrifugation propelled filtration disc and efficient serum-from cells separator
US4490256A (en) * 1982-11-26 1984-12-25 Sartorius Gmbh Apparatus for static membrane filtration
US4811866A (en) * 1987-01-02 1989-03-14 Helena Laboratories Corporation Method and apparatus for dispensing liquids
US4818386A (en) * 1987-10-08 1989-04-04 Becton, Dickinson And Company Device for separating the components of a liquid sample having higher and lower specific gravities
US4957637A (en) * 1988-05-23 1990-09-18 Sherwood Medical Company Serum separator system for centrifuge with piercable membrane
US5393674A (en) * 1990-12-31 1995-02-28 Levine Robert A Constitutent layer harvesting from a centrifuged sample in a tube
US5860937A (en) * 1997-04-30 1999-01-19 Becton, Dickinson & Company Evacuated sample collection tube with aqueous additive
AT409725B (en) * 1997-05-12 2002-10-25 Greiner & Soehne C A SEPARATOR
US9682373B2 (en) 1999-12-03 2017-06-20 Becton, Dickinson And Company Device for separating components of a fluid sample
US20020094305A1 (en) * 1999-12-06 2002-07-18 Dicesare Paul C. Device and method for separating components of a fluid sample
US6803022B2 (en) * 1999-12-06 2004-10-12 Becton, Dickinson And Company Device and method for separating components of a fluid sample
US9393575B2 (en) 2000-04-28 2016-07-19 Harvest Technologies Corporation Blood components separator disk
US9656274B2 (en) 2000-04-28 2017-05-23 Harvest Technologies Corporation Blood components separator disk
US9393576B2 (en) 2000-04-28 2016-07-19 Harvest Technologies Corporation Blood components separator disk
US20040217046A1 (en) * 2001-03-30 2004-11-04 Franz Konrad Holding device, particularly for body fluids, comprising a separating device, and a separating device therefor
US7188734B2 (en) 2001-03-30 2007-03-13 Greiner Bio-One Gmbh Holding device, particularly for bodily fluids, comprising a separating device, and a separating device therefor
US8950586B2 (en) 2002-05-03 2015-02-10 Hanuman Llc Methods and apparatus for isolating platelets from blood
US9897589B2 (en) 2002-05-24 2018-02-20 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US10183042B2 (en) 2002-05-24 2019-01-22 Biomet Manufacturing, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US10393728B2 (en) 2002-05-24 2019-08-27 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US9114334B2 (en) 2002-05-24 2015-08-25 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US8808551B2 (en) 2002-05-24 2014-08-19 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US8603346B2 (en) 2002-05-24 2013-12-10 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US20080223815A1 (en) * 2004-01-23 2008-09-18 Franz Konrad Method for the Assembly of a Cap with a Receptacle
US8448800B2 (en) 2004-01-23 2013-05-28 Greiner Bio-One Gmbh Method for the assembly of a cap with a receptacle
EP2277625A1 (en) 2004-01-23 2011-01-26 Greiner Bio-One GmbH Retaining device for blood, body fluids, tissue samples or tissue cultures
EP1758628A4 (en) * 2004-06-23 2010-07-14 Medikan Co Ltd Syringe piston using in fat transplantation
US8926487B2 (en) 2004-06-23 2015-01-06 Hee Young Lee Method of separating free oil from fat
US7819846B2 (en) * 2004-06-23 2010-10-26 Medikan Co., Ltd. Syringe piston using in fat transplantation
US20080091147A1 (en) * 2004-06-23 2008-04-17 Hee Young Lee Syringe Piston Using in Fat Transplantation
EP1758628A1 (en) * 2004-06-23 2007-03-07 Medikan Co., Ltd. Syringe piston using in fat transplantation
US20070003449A1 (en) * 2005-06-10 2007-01-04 Mehdi Hatamian Valve for facilitating and maintaining fluid separation
US20070102344A1 (en) * 2005-10-04 2007-05-10 Franz Konrad Separating device, holding device and method for separation
US8567609B2 (en) 2006-05-25 2013-10-29 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
WO2008013684A2 (en) * 2006-07-21 2008-01-31 Becton, Dickinson And Company Membrane-based double-layer tube for sample collections
WO2008013684A3 (en) * 2006-07-21 2008-06-05 Becton Dickinson Co Membrane-based double-layer tube for sample collections
US20080164223A1 (en) * 2007-01-05 2008-07-10 Wilson Kelce S Floating filter holder
US7767087B2 (en) * 2007-01-05 2010-08-03 Wilson Kelce S Floating filter holder
US8596470B2 (en) 2007-04-12 2013-12-03 Hanuman, Llc Buoy fractionation system
US9649579B2 (en) 2007-04-12 2017-05-16 Hanuman Llc Buoy suspension fractionation system
US9138664B2 (en) 2007-04-12 2015-09-22 Biomet Biologics, Llc Buoy fractionation system
US8328024B2 (en) 2007-04-12 2012-12-11 Hanuman, Llc Buoy suspension fractionation system
US11725031B2 (en) 2008-02-27 2023-08-15 Biomet Manufacturing, Llc Methods and compositions for delivering interleukin-1 receptor antagonist
US9701728B2 (en) 2008-02-27 2017-07-11 Biomet Biologics, Llc Methods and compositions for delivering interleukin-1 receptor antagonist
US10400017B2 (en) 2008-02-27 2019-09-03 Biomet Biologics, Llc Methods and compositions for delivering interleukin-1 receptor antagonist
US8801586B2 (en) * 2008-02-29 2014-08-12 Biomet Biologics, Llc System and process for separating a material
US8337711B2 (en) 2008-02-29 2012-12-25 Biomet Biologics, Llc System and process for separating a material
US20130196425A1 (en) * 2008-02-29 2013-08-01 Biomet Biologics, Llc System and Process for Separating a Material
US9719063B2 (en) 2008-02-29 2017-08-01 Biomet Biologics, Llc System and process for separating a material
US9714890B2 (en) 2008-07-21 2017-07-25 Becton, Dickinson And Company Density phase separation device
US20100160135A1 (en) * 2008-07-21 2010-06-24 Becton, Dickinson And Company Density Phase Separation Device
US9333445B2 (en) 2008-07-21 2016-05-10 Becton, Dickinson And Company Density phase separation device
US9339741B2 (en) 2008-07-21 2016-05-17 Becton, Dickinson And Company Density phase separation device
US9933344B2 (en) 2008-07-21 2018-04-03 Becton, Dickinson And Company Density phase separation device
US8394342B2 (en) 2008-07-21 2013-03-12 Becton, Dickinson And Company Density phase separation device
US10350591B2 (en) 2008-07-21 2019-07-16 Becton, Dickinson And Company Density phase separation device
US9452427B2 (en) 2008-07-21 2016-09-27 Becton, Dickinson And Company Density phase separation device
US9700886B2 (en) 2008-07-21 2017-07-11 Becton, Dickinson And Company Density phase separation device
US8747781B2 (en) 2008-07-21 2014-06-10 Becton, Dickinson And Company Density phase separation device
US8783470B2 (en) 2009-03-06 2014-07-22 Biomet Biologics, Llc Method and apparatus for producing autologous thrombin
US8992862B2 (en) 2009-04-03 2015-03-31 Biomet Biologics, Llc All-in-one means of separating blood components
US8313954B2 (en) 2009-04-03 2012-11-20 Biomet Biologics, Llc All-in-one means of separating blood components
US9079123B2 (en) 2009-05-15 2015-07-14 Becton, Dickinson And Company Density phase separation device
US10807088B2 (en) 2009-05-15 2020-10-20 Becton, Dickinson And Company Density phase separation device
US11786895B2 (en) 2009-05-15 2023-10-17 Becton, Dickinson And Company Density phase separation device
US20100288694A1 (en) * 2009-05-15 2010-11-18 Becton, Dickinson And Company Density Phase Separation Device
US10376879B2 (en) 2009-05-15 2019-08-13 Becton, Dickinson And Company Density phase separation device
US9364828B2 (en) 2009-05-15 2016-06-14 Becton, Dickinson And Company Density phase separation device
US8794452B2 (en) 2009-05-15 2014-08-05 Becton, Dickinson And Company Density phase separation device
US9731290B2 (en) 2009-05-15 2017-08-15 Becton, Dickinson And Company Density phase separation device
US9802189B2 (en) 2009-05-15 2017-10-31 Becton, Dickinson And Company Density phase separation device
US10343157B2 (en) 2009-05-15 2019-07-09 Becton, Dickinson And Company Density phase separation device
US10456782B2 (en) 2009-05-15 2019-10-29 Becton, Dickinson And Company Density phase separation device
US9919309B2 (en) 2009-05-15 2018-03-20 Becton, Dickinson And Company Density phase separation device
US9919307B2 (en) 2009-05-15 2018-03-20 Becton, Dickinson And Company Density phase separation device
US9919308B2 (en) 2009-05-15 2018-03-20 Becton, Dickinson And Company Density phase separation device
US8998000B2 (en) 2009-05-15 2015-04-07 Becton, Dickinson And Company Density phase separation device
US11351535B2 (en) 2009-05-15 2022-06-07 Becton, Dickinson And Company Density phase separation device
US10413898B2 (en) 2009-05-15 2019-09-17 Becton, Dickinson And Company Density phase separation device
US9011800B2 (en) 2009-07-16 2015-04-21 Biomet Biologics, Llc Method and apparatus for separating biological materials
US9533090B2 (en) 2010-04-12 2017-01-03 Biomet Biologics, Llc Method and apparatus for separating a material
US8591391B2 (en) 2010-04-12 2013-11-26 Biomet Biologics, Llc Method and apparatus for separating a material
US9221049B2 (en) * 2011-03-24 2015-12-29 Boehringer Ingelheim Microparts Gmbh Device and method for removing a supernatant of a liquid sample, and use of a valve device having a soluble membrane
US20140112841A1 (en) * 2011-03-24 2014-04-24 Boehringer Ingelheim Microparts Gmbh Device and method for removing a supernatant of a liquid sample, and use of a valve device having a soluble membrane
US9239276B2 (en) 2011-04-19 2016-01-19 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US9642956B2 (en) 2012-08-27 2017-05-09 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US9895418B2 (en) 2013-03-15 2018-02-20 Biomet Biologics, Llc Treatment of peripheral vascular disease using protein solutions
US10441634B2 (en) 2013-03-15 2019-10-15 Biomet Biologics, Llc Treatment of peripheral vascular disease using protein solutions
US10208095B2 (en) 2013-03-15 2019-02-19 Biomet Manufacturing, Llc Methods for making cytokine compositions from tissues using non-centrifugal methods
US10576130B2 (en) 2013-03-15 2020-03-03 Biomet Manufacturing, Llc Treatment of collagen defects using protein solutions
US10143725B2 (en) 2013-03-15 2018-12-04 Biomet Biologics, Llc Treatment of pain using protein solutions
US9950035B2 (en) 2013-03-15 2018-04-24 Biomet Biologics, Llc Methods and non-immunogenic compositions for treating inflammatory disorders
US9556243B2 (en) 2013-03-15 2017-01-31 Biomet Biologies, LLC Methods for making cytokine compositions from tissues using non-centrifugal methods
US11957733B2 (en) 2013-03-15 2024-04-16 Biomet Manufacturing, Llc Treatment of collagen defects using protein solutions
US9694359B2 (en) 2014-11-13 2017-07-04 Becton, Dickinson And Company Mechanical separator for a biological fluid

Similar Documents

Publication Publication Date Title
US3897337A (en) Plasma separator assembly having interface-seeking piston with centrifugal valve
US3894952A (en) Serum/plasma separator assembly having interface-seeking piston
US3894951A (en) Serum/plasma separator; interface seeking piston; resilient apertures in lower diaphragm type
US3897343A (en) Plasma separator-hydrostatic pressure type
US3941699A (en) Plasma separator with centrifugal valve
US3897340A (en) Serum/plasma separator assembly with interface-seeking piston having coarse and fine band filters
US3945928A (en) Serum/plasma separators with centrifugal valves
US3887466A (en) Serum/plasma separator cannula fluid by-pass type centrifugal valve cannula seal
US3891553A (en) Serum and plasma separator {13 {0 constrictionless type
EP0235244B1 (en) Method and device for separating serum/plasma from blood
US3909419A (en) Plasma separator with squeezed sealant
US3935113A (en) Serum/plasma separator with centrifugal valve
US3779383A (en) Sealed assembly for separation of blood components and method
US3894950A (en) Serum separator improvement with stretchable filter diaphragm
US3951801A (en) Serum/plasma separator-strut stop type
US3687296A (en) Fluid separator
US3882021A (en) Sealed assembly for separation of blood with anti-red cell barrier
US3931010A (en) Serum/plasma separators with centrifugal valves
US3957654A (en) Plasma separator with barrier to eject sealant
US4202769A (en) Method for separating serum or plasma from the formed elements of blood
US4152270A (en) Phase separation device
US4055501A (en) Fluid collection device with phase partitioning means
US3849072A (en) Plasma separator
US3887464A (en) Serum/plasma separator with centrifugal valve seal
US3096283A (en) Container for blood and machine for separating precipitates from liquid blood constituents